Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

MitoKor

MitoKor is Pioneering Mitochondrial Medicine™ by developing therapeutic solutions for diseases, based on mitochondrial research. Mitochondria are the self-charging batteries of cells, driving energy production, metabolism, and cellular life and death, as well as participating in other key signaling pathways. Mitochondria also house the "other" human genome, inherited only from the mother. Mitochondrial dysfunction is a significant contributing factor in the pathophysiology of major diseases such as Alzheimer's and Parkinson's diseases, osteoarthritis, and type 2 diabetes mellitus. MitoKor and its wholly-owned subsidiaries, Mimotopes and Apollo BioPharmaceutics, have established core competencies in biotechnology, combinatorial drug discovery, target discovery, assay and diagnostic development, as well as in mitochondrial and nuclear proteomics and genomics, disease modeling and pharmacogenomics.

MitoKor is headquartered in San Diego, California, with satellite facilities in Cambridge, Massachusetts, and Melbourne, Australia, and also maintains world-wide marketing and sales facilities in North America, Europe, and Asia. The Company's 50,000-sq. ft. R&D facilities and over 120 employees are divided approximately equally between the San Diego and Melbourne locations.



The company broadens its research base by maintaining and supporting collaborative relationships with a large number of academic centers. MitoKor has been awarded over $1 million in federal and state research grants.


Contact Details:
11494 Sorrento Valley Road
San Diego
CA
92121
United States of America
Tel:(858) 793 7800
Fax:(858) 793 7805
Email:
WWW:

www.mitokor.com/




Loading...

Recent Publications by MitoKor:

Excitotoxic injury to mitochondria isolated from cultured neurons.
Neuronal death in response to excitotoxic levels of glutamate is dependent...
24th September, 2005
MitoKor, San Diego, CA 92121, USA. J Biol Chem. 2005 Aug 12;280(32):28894-902. Epub 2005 Jun 2.
DOI Direct Link
Ectopic expression of the human adenine nucleotide translocase, isoform 3 (ANT-3). Characterization of ligand binding properties.
The adenine nucleotide translocase (ANT) is a key component in maintaining...
16th September, 2005
MitoKor, Mitochondrion. 2005 Feb;5(1):1-13.
Co-segregation and heteroplasmy of two coding-region mtDNA mutations within a matrilineal pedigree.
The ENG1 Leber's hereditary optic neuropathy (LHON) family spans six...
22nd April, 2005
MitoKor Inc., 12780 High Bluff Drive, Suite 210, San Diego, CA 92130, USA. Hum Genet. 2005 Jan;116(1-2):28-32. Epub 2004 Nov 3.
DOI Direct Link
African Haplogroup L mtDNA sequences show violations of clock-like evolution.
A set of 96 complete mtDNA sequences that belong to the three major...
5th March, 2005
MitoKor Inc., Mol Biol Evol. 2004 Oct;21(10):1843-54. Epub 2004 Jun 9.
DOI Direct Link
Photoreceptor preservation in the S334ter model of retinitis pigmentosa by a novel estradiol analog.
The cytoprotective activity of MITO-4565, a novel, non-hormonal, estradiol...
26th January, 2005
MitoKor Inc., 11494 Sorrento Valley Road, San Diego, CA 92121, USA. Biochem Pharmacol. 2004 Nov 15;68(10):1971-84.
DOI Direct Link

View more MitoKor research publications.

Press Releases on MitoKor:

BioPortfolio Logo
MIGENIX Reports Fourth Quarter and Fiscal Year 2008 Financial Results 21st July, 2008 MIGENIX Inc.
VANCOUVER and SAN DIEGO, July 21 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, reports financial results for the three

MitoKor Patents:

US Patent No.Title
6900197 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
6280966 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
6268398 Compounds and methods for treating mitochondria-associated diseases
6265219 Transponder tagging of constituents used in compound synthesis
6218117 Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios

View more MitoKor patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1011 times since April 2007, the link to the organisation's website has been followed 278 times

Recent Search Terms used to find this page: MitoKor San Diego California | mitokor san diego | MitoKor | mitokor san diego | mitokor | mitokor san diego | mitokor san diego | Mitokor San Diego CA | mitokor | MitoKor San Diego CA | .

Search for more companies in San Diego

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for MitoKor

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.